United States. Department of Health and Human Services. Office of Behavioral Health, Disability, and Aging Policy, issuing body.
Publication:
Washington, D.C. : HHS Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy, January 2022
Fetal Alcohol Spectrum Disorders (FASD) is a non-diagnostic umbrella term used to describe the range of disability that can result from prenatal alcohol exposure (PAE). FASD is estimated to affect as many as 11 to 50 per 1,000 children in the United States. FASD affects individuals throughout their life course and the condition can involve cognitive, behavioral, and physical health issues. The treatment and care of individuals with FASD can involve multiple systems on the federal, state and local levels, including the health care system (especially in the behavioral health care system), the child welfare system, the criminal justice system, and the long-term disability care system. The total lifetime costs have been estimated to be approximately $2 million per affected individual. FASD is preventable, and much of the associated disability and costs to systems, families, and individuals can be reduced with the implementation of effective public health policies and programs. Since state agencies are positioned to have a significant impact on FASD polices, we provide an overview of successful strategies employed by various states. As comprehensive state FASD policies and programs must address three main components to adequately address the multiple facets of FASD--(1) prevention; (2) early identification; and (3) intervention--we organize this brief to provide strategies to address each of the three components. This brief is based on findings from an environmental scan of peer-reviewed and grey literature and a meeting of nationally known experts on FASD that the Office of the Assistant Secretary for Planning and Evaluation (ASPE) held in September 2019 to discuss policies on prevention, identification, and interventions with individuals affected by FASD.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)